http://orcid.org/0000-0002-4835-1032
About the Authors
- Simon P. Jochems
-
* E-mail: simon.jochems@lstmed.ac.uk (SPJ); Daniela.ferreira@lstmed.ac.uk (DMF)
Affiliation Department of Clinicial Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
- Jeffrey N. Weiser
-
Affiliation Department of Microbiology, New York University School of Medicine, New York, New York, United States of America
- Richard Malley
-
Affiliation Division of Infectious Diseases, Boston Children′s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
- Daniela M. Ferreira
-
* E-mail: simon.jochems@lstmed.ac.uk (SPJ); Daniela.ferreira@lstmed.ac.uk (DMF)
Affiliation Department of Clinicial Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Competing Interests
I have read the journal′s policy and have the following conflicts: RM is a named inventor on filed patents related to vaccine technologies and is a scientific founder, consultant, and equity owner at Affinivax, a biotechnology company based in Cambridge, MA that is devoted to the development of vaccines for developing and developed countries. RM is also a paid consultant to Merck & Co. in the area of adult immunizations. JNW receives royalties for a pneumococcal vaccine from GlaxoSmithKline Co. JNW has a financial interest in Merck & Co., which produces a pneumococcal vaccine.